(Q45947620)

18 December 2017

title

Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas. (English)

1 reference

18 December 2017

dedifferentiated liposarcoma

main subject

1 reference

Andrew E Horvai

1

1 reference

18 December 2017

Jochen T Schaefer

series ordinal

2

1 reference

18 December 2017

Eric K Nakakura

series ordinal

3

1 reference

18 December 2017

Richard J O'Donnell

series ordinal

4

1 reference

18 December 2017

publication date

18 January 2008

1 reference

18 December 2017

published in

Modern Pathology

1 reference

18 December 2017

volume

21

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

517-524

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1038/modpathol.3801017

exact match

0 references

cites work

Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

The MDM2 gene amplification database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

MDM2 and CDK4 gene amplification in Ewing's sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

A phase II trial with rosiglitazone in liposarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

c-Kit is not expressed in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Can PPAR gamma ligands be used in cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Therapeutic potential of thiazolidinediones as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

7 January 2021

Reproducibility of MDM2 and CDK4 staining in soft tissue tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

7 January 2021

MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

7 January 2021

Liposarcoma with meningothelial-like whorls: a study of 17 cases of a distinctive histological pattern associated with dedifferentiated liposarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

7 January 2021

Dedifferentiated liposarcoma: a report of nine cases with a peculiar neurallike whorling pattern associated with metaplastic bone formation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

7 January 2021

Chromosome 12 origin in rings and giant markers in well-differentiated liposarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

7 January 2021

Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

7 January 2021

Immunoreactivity of p53, Mdm2, p21(WAF1/CIP1) Bcl-2, and Bax in soft tissue sarcomas: correlation with histologic grade

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

7 January 2021

A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801017

7 January 2021

10.1038/MODPATHOL.3801017

Identifiers

DOI

1 reference

18 December 2017

Dimensions Publication ID

0 references

1 reference

18 December 2017